New Biosimilar Approvals for Myeloid Growth Factors and Anemia.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2019.5016
Abstract: Biosimilars are here to stay, but whether they will enjoy widespread uptake remains to be seen. The FDA sets a high bar for approval of biosimilar products, yet many clinicians remain skeptical about the efficacy… read more here.
Keywords: factors anemia; biosimilar approvals; myeloid growth; growth factors ... See more keywords